ArticleInflammation2026

Pharmacological Characterization of GLPG3667, a Tyrosine Kinase 2-Selective Inhibitor, for the Treatment of Inflammatory and Autoimmune Diseases.

Céline Cottereaux et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.